Literature DB >> 2774512

Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months.

R A Koopmans1, D K Li, J J Oger, L F Kastrukoff, C Jardine, L Costley, S Hall, E W Grochowski, D W Paty.   

Abstract

Eight patients in the chronic progressive stage of multiple sclerosis were studied prospectively with magnetic resonance imaging of the head and neurological examination every 2 weeks for 6 months. There were no clinical relapses and disability ratings did not change between the start and completion of the study. Despite the clinical inactivity, a total of 86 active events (new, reappearing, or enlarging lesions) were identified by magnetic resonance imaging over the 6 months, with 50 (51%) of 98 follow-up scans showing evidence of one or more active lesions. New and changing lesions were indistinguishable in appearance, distribution, and temporal pattern from those previously seen in patients who had relapsing and remitting multiple sclerosis. However, as noted previously, the patients in the chronic progressive stage had many more confluent lesions than did the group in relapse. These results strongly suggest that the frequently observed clinical evolution of multiple sclerosis into a chronic progressive course is not accompanied by a fundamental change in the disease process. In fact the chronic progressive stage seems associated with more active changes demonstrated by scans than does relapsing and remitting multiple sclerosis. This study also confirms our previous experience that serial magnetic resonance imaging is much more sensitive than clinical examination in detecting disease activity in multiple sclerosis.

Entities:  

Mesh:

Year:  1989        PMID: 2774512     DOI: 10.1002/ana.410260211

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Neuropsychological and psychiatric aspects of multiple sclerosis: preliminary investigation of discrete profiles across neurological subtypes.

Authors:  Marina Katsari; Dimitrios Kasselimis; Gerasimos Gasparinatos; Roubina Antonellou; Konstantinos Voumvourakis
Journal:  Neurol Sci       Date:  2016-01-07       Impact factor: 3.307

2.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

3.  Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging.

Authors:  C Mariani; E Farina; S F Cappa; G P Anzola; L Faglia; L Bevilacqua; R Capra; F Mattioli; L A Vignolo
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

Review 4.  Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Authors:  J H Simon
Journal:  West J Med       Date:  1996-06

5.  Database for serial magnetic resonance imaging in multiple sclerosis.

Authors:  F Barkhof; A J Thompson; L Kappos; J J Nauta; T Yousri; I Berry; G Scotti; B Appel; P S Tofts; D H Miller
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.

Authors:  M R Piras; I Magnano; E D G Canu; K S Paulus; W M Satta; A Soddu; M Conti; A Achene; G Solinas; I Aiello
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

Review 7.  Multiple sclerosis and pregnancy.

Authors:  A R Lorenzi; H L Ford
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

Review 8.  Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis.

Authors:  George Saitakis; Bart K Chwalisz
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.